Mass Torts

March 4, 2023

Hair Relaxer Myomectomy Lawsuit

Most of our hair relaxer uterine fibroid lawsuits involve women who require a hysterectomy to treat their condition. But our lawyers are also seeing claims from victims who need a myomectomy to treat fibroids that chemical hair straighteners may have caused.

We believe myomectomy claims may also receive significant settlement compensation in the new hair relaxer class action lawsuit.

The page talks about myomectomy lawsuits in this litigation and speculates about the settlement payouts victims might receive. Elsewhere, we give you the latest hair relaxer lawsuit update tracking where we are in the litigation.

March 1, 2023

Luster’s Smooth Touch Hair Relaxer Lawsuit

by Ronald V. Miller, Jr.

New scientific evidence has established a link between female cancers (ovarian and uterine) and long-term use of chemical hair relaxers. Luster’s Smooth Touch and Luster’s Pink are two famous chemical hair relaxers/straighteners. Many women who used Smooth Touch, Pink, or other Luster relaxer products and subsequently developed uterine cancer, ovarian cancer, uterine fibroids, or endometriosis may be able to file a hair relaxer lawsuit and get financial compensation. Hair relaxer cancer lawsuits are already being filed around the country. Hair relaxer cases in federal courts have already been consolidated into a new class action lawsuit.

This post will examine the recent medical evidence linking relaxers to uterine and ovarian cancer and the lawsuits against Luster Products Inc. regarding its Smooth Touch and Pink line of relaxer products.

About Luster’s Smooth Touch and Other Hair Relaxer Products

February 28, 2023

Trifecta Valve Problems

by Ronald V. Miller, Jr.

Federal health officials have issued a warning about certain heart valve replacement devices made by Abbott. These devices, called the Trifecta Valve and the Trifecta Valve with Glide Technology, may deteriorate much faster than other similar devices. This could lead to patients needing another surgery to replace the valve sooner than expected or even experiencing serious and life-threatening health problems.

The Trifecta and Trifecta GT valves are used to treat people with heart valve problems, specifically with the aortic heart valve, which is an important valve that helps the heart function properly. The valves are intended as a replacement for a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.

The FDA approved the first-generation Trifecta valve in 2011, but it is no longer sold – with good reason – in the United States. The Trifecta GT valve, which was approved in 2016, is currently the only Abbott heart valve replacement device still available in the United States. It was approved with the hope that this new tissue valve would offer enhancements that would make the implantation process smoother, providing a solution to patients, even those with more challenging cases.

February 28, 2023

New Eye Drops Recall Lawsuit

by Ronald V. Miller, Jr.

Plaintiff Richard Mosley, a resident of Kentucky, filed a consumer class action lawsuit against EzriCare LLC, EzriRx LLC, Delsam Pharma LLC, Global Pharma Healthcare Private Limited, and Aru Pharma Inc. for manufacturing, importing, selling, marketing, labeling, and distributing artificial tears contaminated with a rare and drug-resistant strain of Pseudomonas aeruginosa bacteria. This is not really a personal injury lawsuit. The focus here is refund for anyone who bought these products. The plaintiff seeks injunctive relief and restitution for the full purchase price of the artificial tear products. Our firm is just handling the personal injury eye drops lawsuits. But we write about this lawsuit because the core allegation are the same as they would be for a Deslam or Ezricare personal injury or wrongful death claim

The Contamination

The artificial tears, which contain Carboxymethylcellulose Sodium 10 MG in 1 ml, are alleged to be adulterated and contaminated due to the Defendants’ violations of Current Good Manufacturing Processes. These violations include lack of appropriate microbial testing, formulation issues, and inadequate preservatives in multi-use bottles.

February 18, 2023

Hair Relaxer Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

How much will a hair relaxer lawsuit be worth? Victims have many questions about hair relaxer settlements. But the biggest question we get is what settlement payouts can victims expect.

The emergence of the hair relaxer class action lawsuit has prompted speculation on how this litigation will play out and what a hair relaxer global settlement payout might look like.

In this post, our lawyers will look at the potential settlement value of hair relaxer lawsuits involving uterine cancer, and other conditions linked to hair relaxers.

February 18, 2023

Hair Relaxer Endometrial Cancer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are helping victims seek hair relaxer settlements throughout the country. This page is about how chemical hair straighteners can cause endometrial cancer.

African American women are nearly twice as likely to die from endometrial cancer. Why? Everyone knew this. No one bothered to dig into all of the possible reasons why. Hair relaxer lawsuits allege that L’oreal (Dark & Lovely) and other makers of hair relaxers put their heads in the sand and put women at risk.

A major new study from NIH has found that long-term use of chemical hair straighteners and/or relaxers can significantly increase the risk of endometrial cancer (and other female hormone cancers). This new evidence connecting hair relaxers and endometrial cancer has prompted product liability lawsuits against cosmetic companies.

February 17, 2023

Hair Relaxer Uterine Cancer Lawsuit

by Ronald V. Miller, Jr.

New research has shown that women who use chemical hair straighteners and/or relaxers are at a higher risk of uterine cancer. This new evidence linking hair perms and straighteners and uterus cancer has led to a wave of hair relaxer cancer uterine cancer lawsuits against cosmetic companies like L’Oreal and Revlon.

There is now a national hair relaxer class action lawsuit that houses uterine cancer claims. Our lawyers are now actively seeking women who want to seek a hair relaxer settlement for uterine cancer based on the following criteria:

You used chemical hair relaxers or hair straightener products at least three times per year for 7-10 years.

February 14, 2023

Delsam Eye Drops Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are reviewing Delsam Pharma eye drops lawsuits in all 50 states after the eye drops have been linked to an outbreak of bacterial infections.

At least one person has died from the infection, and other victims have suffered blindness, vision impairment and other serious health conditions. Now the Delsam Artificial Tears eye drops have been recalled nationwide. These eye drops lawsuits could bring large settlement payouts because the injuries for many will be very significant.

Delsam Pharma Eye Drops

January 24, 2023

PFAS Cancer Lawsuit (AFFF)

by Ronald V. Miller, Jr.

This page is about the AFFF/PFAS lawsuit. Our lawyers are handling firefighting foam lawsuits throughout the United States.

AFFF lawsuits are based on studies showing that Per- and polyfluoroalkyl substances are linked to severe adverse health effects, particularly various cancers. This is a public health concern, because of how prevalent PFAS are in both manufactured products and the environment.

January 2023 PFAS Class Action Update

January 18, 2023

Potential Januvia Cancer Lawsuit

by Ronald V. Miller, Jr.

Yesterday, the FDA warned that “certain samples of sitagliptin” were found to contain a nitrosamine called NTTP (nitroso-STG-19). NTP can cause cancer. So there is a concern.

How serious is the concern? We do not know yet. Our lawyers are not yet taking new Januvia cancer lawsuits. But this is something to keep an eye on… because we do not know much yet.

January 2023 Update